Vascular endothelial growth factor a modified mRNA engineered cellular electrospun membrane complexes promotes mouse skin wound repair
Source abstract
Abstract
Artificial skin substitutes are one of the most promising areas of wound healing research; however, graft survival largely depends on how the treatment is performed. Early angiogenesis is essential for wound healing and graft survival and vascular endothelial growth factor A (VEGFA) is an important cytokine that stimulates angiogenesis. Here, we first investigated the effects of different ratios of collagen (BC) and gelatin blended with poly (l-lactide-co-caprolactone) (PLCL) on nanofibrous membranes. The Young's modulus and cell proliferation were significantly higher in the 50% BC group than that in all other groups. Then, cellular electrospun membrane complexes (CEMC) were successfully constructed from nanoscaffolds and fibroblasts extracted from human foreskin and engineered with controlled autocrine VEGFA by transfecting VEGFA modified mRNA (modRNA). Engineered CEMC significantly promoted wound healing in vivo and contributed to stable vascular network formation in the grafted area, thereby increasing the survival rate of the engineered skin. This study provides a potential solution for wound healing while establishing the value of different RNA modification methods for various engineered skins in the future, thereby advancing engineered skin development.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments · Silk-based biomaterials and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Biomaterials to mimic and heal connective tissues10.1002/adma.201806695 ↗
2. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab10.1002/jso.20301 ↗
3. Instructive microenvironments in skin wound healing: biomaterials as signal releasing platforms10.1016/j.addr.2018.03.012 ↗
4. Epidermal skin grafting10.1111/iwj.12631 ↗
5. Long-lasting treatment for moderate-severe depressed facial scars: skin and hair derived new autologous tissue filler with subcision10.1080/09546634.2020.1748854 ↗
6. Guiding stem cell differentiation into oligodendrocytes using graphene-nanofiber hybrid scaffolds10.1002/adma.201400523 ↗
7. A functional PVA aerogel-based membrane obtaining sutureability through modified electrospinning technology and achieving promising anti-adhesion effect after cardiac surgery
8. Silk fibroin/poly-(L-lactide-co-caprolactone) nanofiber scaffolds loaded with Huangbai Liniment to accelerate diabetic wound healing10.1016/j.colsurfb.2021.111557 ↗
9. The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction10.1002/jbm.a.32609 ↗
10. Protein nanocoatings on synthetic polymeric nanofibrous membranes designed as carriers for skin cells10.2147/IJN.S121299 ↗
11. Polypyrrole-coated poly(l-lactic acid-co-ε-caprolactone)/silk fibroin nanofibrous membranes promoting neural cell proliferation and differentiation with electrical stimulation10.1039/C6TB01710J ↗
12. Electrospun gelatin/PCL and collagen/PLCL scaffolds for vascular tissue engineering10.2147/IJN.S61375 ↗
13. Biocompatibility assessment of PLCL-sericin copolymer membranes using wharton's jelly mesenchymal stem cells
14. Cardiomyocyte-driven actuation in biohybrid microcylinders10.1002/adma.201501284 ↗
15. Gelatin/polycaprolactone electrospun nanofibrous membranes: the effect of composition and physicochemical properties on postoperative cardiac adhesion10.3389/fbioe.2021.792893 ↗
16. A fibrous hybrid patch couples cell-derived matrix and poly(l-lactide--caprolactone) for endothelial cells delivery and skin wound repair10.1021/acsbiomaterials.8b01118 ↗
17. Natural composite dressings based on collagen, gelatin and plant bioactive compounds for wound healing: a review10.1016/j.ijbiomac.2019.07.155 ↗
18. Collagen and gelatin10.1146/annurev-food-031414-111800 ↗
19. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse10.1007/s00125-003-1064-1 ↗
20. Vascular endothelial growth factor and angiogenesis10.1124/pr.56.4.3 ↗
21. Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing10.1038/sj.mt.6300041 ↗
22. Enhanced wound healing by topical administration of mesenchymal stem cells transfected with stromal cell-derived factor-110.1016/j.biomaterials.2013.08.053 ↗
23. Adipose-derived stromal cells overexpressing vascular endothelial growth factor accelerate mouse excisional wound healing10.1038/mt.2012.234 ↗
24. Advances in gene therapy and their application to skin diseases: a review10.1016/j.jdermsci.2021.05.004 ↗
25. Hot spots of retroviral integration in human CD34+ hematopoietic cells10.1182/blood-2007-01-068759 ↗
26. Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy10.1038/mt.2011.178 ↗
27. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences10.1371/journal.pbio.0020234 ↗
28. mRNA-based therapeutics--developing a new class of drugs, Nature reviews10.1038/nrd4278 ↗
29. Ai · 2022
30. Comparative study of collagen and gelatin in chitosan-based hydrogels for effective wound dressing: physical properties and fibroblastic cell behavior10.1016/j.bbrc.2019.08.102 ↗
31. An avascular niche created by axitinib-loaded PCL/collagen nanofibrous membrane stabilized subcutaneous chondrogenesis of mesenchymal stromal cells10.1002/advs.202100351 ↗
32. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction10.1038/nbt.2682 ↗
33. Insight into reepithelialization: how do mesenchymal stem cells perform?
34. Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies10.1186/s13287-019-1212-2 ↗
35. Re-epithelialization of adult skin wounds: cellular mechanisms and therapeutic strategies10.1016/j.addr.2018.06.019 ↗
36. The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (epsilon-caprolactone)/collagen fibers and hyaluronic acid hydrogel10.1016/j.biomaterials.2011.07.022 ↗
37. Novel electrospun chitosan/polyvinyl alcohol/zinc oxide nanofibrous mats with antibacterial and antioxidant properties for diabetic wound healing10.1016/j.ijbiomac.2018.08.057 ↗
38. Electrospun gelatin/poly(L-lactide-co-epsilon-caprolactone) nanofibers for mechanically functional tissue-engineering scaffolds10.1163/156856208783721029 ↗
39. Co-electrospun nanofiber fabrics of poly(L-lactide-co-epsilon-caprolactone) with type I collagen or heparin10.1021/bm050086u ↗
40. The effect of gelatin incorporation into electrospun poly(L-lactide-co-epsilon-caprolactone) fibers on mechanical properties and cytocompatibility10.1016/j.biomaterials.2007.12.029 ↗
41. Synthesis of poly(l-lactide-co-ε-caprolactone) copolymer: structure, toughness, and elasticity10.3390/polym13081270 ↗
42. Wound healing: a cellular perspective10.1152/physrev.00067.2017 ↗
43. RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications10.1007/s12265-013-9494-8 ↗
44. Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway10.1155/2015/858349 ↗
45. Innovative treatment strategies to accelerate wound healing: trajectory and recent advancements10.3390/cells11152439 ↗
46. Factors affecting wound healing10.1177/0022034509359125 ↗
47. The keloid disorder: heterogeneity, histopathology, mechanisms and models10.3389/fcell.2020.00360 ↗